Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass

Next Previous
X
Search
Trial Profile

A Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 16 Mar 2022

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Levosimendan (Primary)
  • Indications Low cardiac output
  • Focus Registrational; Therapeutic Use
  • Acronyms LEVO-CTS
  • Sponsors Tenax Therapeutics

    • Most Recent Events

    • 06 Mar 2022 Results describing variables and outcomes associated with peri-operative mechanical circulatory support utilization among patients enrolled in the Levosimendan in patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery, published in the American Heart Journal
    • 27 Oct 2020 Results (n=854) of post hoc analysis assessing association between levosimendan, postoperative AKI, and mortality in cardiac surgery published in the American Heart Journal
    • 18 Nov 2019 Results (n=854) assessing clinical outcomes compared between patients with and without AKI were presented at the American Heart Association Scientific Sessions 2019

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top